Phase 1 Trial of Navitoclax and Sorafenib in Patients with Relapsed or Refractory Solid Tumors with Hepatocellular Carcinoma Expansion Cohort.
Journal of Clinical Oncology(2024)
Key words
ABT-263,Navitoclax,Sorafenib,BCL2,Hepatocellular carcinoma
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined